![Neoepitopes as cancer immunotherapy targets: key challenges and opportunities](https://www.lifetein.com/blog/wp-content/uploads/2018/09/Neoepitopes-as-cancer-immunotherapy-targets-key-challenges-and-opportunities-1024x527.jpg)
- Design a biotin-labeled peptide library: overlapping or Alanine scan
- The peptide library is coated on the avidin-coated 96 well plates.
- The Peptide library is used to evaluate the binding of each peptide to different cell lines using CyQUANT Cell Proliferation Assays.
- Flow cytometry: Determine the cellular uptake of selected FITC-labeled peptides.
- Competitive assay: The cells are incubated with FITC-peptide with or without excess unlabeled peptide (100-fold)
- Finetune the peptide sequence: structure analysis, cyclization, and D amino acid modification.
- Find the promising receptor-specific cancer cell binding peptide that can be conjugated directly to a chemotherapeutic drug or to nanoparticles for targeted drug delivery to enhance the efficacy of chemotherapy for cancer treatment.
Reference: